<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.loc.gov/METS/ https://www.loc.gov/standards/mets/mets.xsd" OBJID="oai:wwu.de:94bab196-ece9-408d-adc2-7b54d937c8fe" LABEL="University of Muenster, Institutional Repository MIAMI"  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
          <mets:metsHdr CREATEDATE="2022-04-07T09:46:43">
            <mets:agent TYPE="OTHER" ROLE="OTHER" OTHERTYPE="SOFTWARE">
              <mets:name>Memory Alpha</mets:name>
            </mets:agent>
          </mets:metsHdr>
          <mets:dmdSec ID="DMD_94bab196-ece9-408d-adc2-7b54d937c8fe">
            <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
              <mets:xmlData>
                <mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd" version="3.7">
                  <mods:titleInfo type="uniform" lang="eng">
                    <mods:title script="Latn">The role of HIVEP1 in endothelial platelet interaction in the context of venous thrombosis</mods:title>
                  </mods:titleInfo>
                  <mods:titleInfo type="translated" lang="ger">
                    <mods:title script="Latn">Die Regulation der Thrombozyten-Endothel-Interaktion durc HIVEP1 im Kontext venöser Thrombose</mods:title>
                  </mods:titleInfo>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/1188578073">
                    <mods:namePart type="given">Simon</mods:namePart>
                    <mods:namePart type="family">Baar</mods:namePart>
                    <mods:namePart type="date">1990-</mods:namePart>
                    <mods:displayForm>Baar, Simon</mods:displayForm>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">aut</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/1027044093">
                    <mods:namePart type="given">Stefan-Martin</mods:namePart>
                    <mods:namePart type="family">Brand</mods:namePart>
                    <mods:displayForm>Brand, Stefan-Martin</mods:displayForm>
                    <mods:affiliation>FB 05: Medizinische Fakultät</mods:affiliation>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">ths</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Universitäts- und Landesbibliothek Münster</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>ULB Münster</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Landesbibliothek Münster / Universitäts- und Landesbibliothek Münster</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Universität Münster / Universitäts- und Landesbibliothek</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:genre>doctoralThesis</mods:genre>
                  <mods:genre authority="dct">Text</mods:genre>
                  <mods:originInfo>
                    <mods:dateIssued keyDate="yes">2019</mods:dateIssued>
                    <mods:dateOther>2019-04-12</mods:dateOther>
                    <mods:issuance>monographic</mods:issuance>
                  </mods:originInfo>
                  <mods:originInfo>
                    <mods:dateIssued encoding="w3cdtf">2019-06-17</mods:dateIssued>
                    <mods:dateModified encoding="w3cdtf">2019-07-19</mods:dateModified>
                    <mods:edition>[Electronic ed.]</mods:edition>
                  </mods:originInfo>
                  <mods:language>
                    <mods:languageTerm type="code" authority="iso639-2b">eng</mods:languageTerm>
                  </mods:language>
                  <mods:physicalDescription>
                    <mods:form>electronic</mods:form>
                    <mods:reformattingQuality>access</mods:reformattingQuality>
                    <mods:internetMediaType>application/pdf</mods:internetMediaType>
                    <mods:digitalOrigin>born digital</mods:digitalOrigin>
                  </mods:physicalDescription>
                  <mods:abstract lang="ger">In ersten Genomweiten Assoziationsstudien zur venösen Thrombose (VT) wurde das human immunodeficiency virus type I enhancer-binding protein 1 (HIVEP1) als potentiell prädisponierender Faktor identifiziert. In dieser Arbeit analysierten wir die bislang unbekannte Funktion von HIVEP1. Nach Etablierung eines in vitro Modells zur endothelialen Thrombozyten-Adhäsion beobachteten wir eine signifikant reduzierte Adhäsion durch endothelialen HIVEP1 siRNA-Knockdown. Stimulation von endothelialem PECAM1 führte ebenfalls zu einer verringerten Thrombozyten-Adhäsion bei gleichzeitig mehr PECAM1 auf der Zelloberfläche. Wir konnten zeigen, dass ein HIVEP1 Knockdown in Endothelzellen zu einer erhöhten Menge an PECAM1 führt, sowohl insgesamt als auch an der Zell-Oberfläche. Daraus schlussfolgern wir, dass HIVEP1 möglicherweise durch Förderung der endothelialen Thrombozyten-Adhäsion an der Pathogenese von VT beteiligt ist und diese Funktion wahrscheinlich durch Regulation von PECAM1 vermittelt.</mods:abstract>
                  <mods:abstract lang="eng">In genome-wide association studies on venous thrombosis (VT), the human immunodeficiency virus type I enhancer-binding protein 1 (HIVEP1) has been identified as potential susceptibility factor. &#13;
In this work, we analyzed the previously unknown function of HIVEP1. After establishing an in vitro endothelial platelet adhesion assay, we observed that endothelial HIVEP1 siRNA-knockdown leads to significantly reduced platelet adhesion. Activation of endothelial PECAM1 also led to reduced platelet adhesion while at the same time increasing the amount of cell-surface PECAM1. We could show that endothelial HIVEP1 knockdown led to increased levels of endothelial total and cell-surface PECAM1. &#13;
We therefore conclude that HIVEP1 may be involved in the pathogenesis of VT as contributing factor in the process of endothelial platelet adhesion. HIVEP1 may exert its action via regulating endothelial PECAM1.</mods:abstract>
                  <mods:tableOfContents lang="eng">LIST OF FIGURES ......................................................................................................... I&#13;
LIST OF TABLES .......................................................................................................... II&#13;
ABBREVIATIONS ....................................................................................................... III&#13;
ABSTRACT ................................................................................................................ VI&#13;
1 INTRODUCTION ...................................................................................................... 1&#13;
1.1 Vascular disorders - Thrombosis ............................................................................................................ 1&#13;
1.1.1 Hemostasis and coagulation ................................................................................................................................. 1&#13;
1.1.2 Platelet adhesion and aggregation .................................................................................................................... 4&#13;
1.1.3 Arterial thrombosis .................................................................................................................................................. 5&#13;
1.1.4 Venous thrombosis ................................................................................................................................................... 6&#13;
1.1.5 The Role of the Endothelium ................................................................................................................................ 7&#13;
1.2 Genetic diseases ............................................................................................................................................ 9&#13;
1.3 Human immunodeficiency virus type I enhancer binding protein 1 (HIVEP1) .................... 10&#13;
1.4 Aim of the study .......................................................................................................................................... 11&#13;
2 MATERIALS ........................................................................................................... 12&#13;
2.1 Chemicals ...................................................................................................................................................... 12&#13;
2.2 Sera, media and supplements ................................................................................................................ 13&#13;
2.3 Consumables and kits ............................................................................................................................... 13&#13;
2.4 Antibodies .................................................................................................................................................... 14&#13;
2.5 Eukaryotic cells .......................................................................................................................................... 15&#13;
2.6 Laboratory equipment ............................................................................................................................. 15&#13;
2.7 Software ........................................................................................................................................................ 16&#13;
3 METHODS ............................................................................................................. 17&#13;
3.1 Eucaryotic cells ........................................................................................................................................... 17&#13;
3.1.1 Cell culture ................................................................................................................................................................ 17&#13;
3.1.2 Storage ........................................................................................................................................................................ 17&#13;
3.1.3 Stimulation ................................................................................................................................................................ 18&#13;
3.1.4 Transient HIVEP1-knockdown ......................................................................................................................... 18&#13;
3.1.5 Antibodies ................................................................................................................................................................. 19&#13;
3.2 Microscopy of patients’ histological samples ................................................................................... 20&#13;
3.3 Adhesion assays ......................................................................................................................................... 21&#13;
3.4 Immunofluorescence ................................................................................................................................ 22&#13;
3.5 Enzyme-linked immunosorbent assay (ELISA) ............................................................................... 22&#13;
3.6 Recovery of cell-surface PECAM1 ......................................................................................................... 23&#13;
3.7 Immunoblot ................................................................................................................................................. 23&#13;
3.7.1 Protein extraction .................................................................................................................................................. 23&#13;
3.7.2 Protein quantification .......................................................................................................................................... 24&#13;
3.7.3 SDS-Polyacrylamide Gel Electrophoresis (PAGE) .................................................................................... 24&#13;
3.7.4 Western blot (tank blot) ...................................................................................................................................... 25&#13;
3.8 Immunoprecipitation ............................................................................................................................... 26&#13;
3.9 Statistical methods .................................................................................................................................... 26&#13;
4 RESULTS ................................................................................................................ 27&#13;
4.1 HIVEP1 and PECAM1 in patients with thrombosis ......................................................................... 27&#13;
4.2 HIVEP1 in endothelial-platelet adhesion .......................................................................................... 31&#13;
4.3 PECAM1 in endothelial-platelet adhesion ......................................................................................... 32&#13;
4.4 Endothelial cell-surface PECAM1 ......................................................................................................... 33&#13;
4.4.1 CD31 mAb .................................................................................................................................................................. 33&#13;
4.4.2 hCD31 peptide ......................................................................................................................................................... 35&#13;
4.5 Regulation of cell-surface PECAM1 ...................................................................................................... 36&#13;
4.5.1 Recovery of endothelial cell-surface PECAM1 ........................................................................................... 37&#13;
4.5.2 TNF-alpha .................................................................................................................................................................. 38&#13;
4.6 Regulation of PECAM1 through HIVEP1 ............................................................................................. 39&#13;
4.6.1 Effect of HIVEP1 knockdown on PECAM1 protein level ....................................................................... 39&#13;
4.6.2 Effect of HIVEP1 knockdown on cell-surface PECAM1 .......................................................................... 40&#13;
4.7 Analyzing direct HIVEP1-PECAM1-interaction ................................................................................ 41&#13;
5 DISCUSSION .......................................................................................................... 44&#13;
5.1 HIVEP1 is localized at sites of thrombosis ........................................................................................ 44&#13;
5.2 Role of endothelial PECAM1 ................................................................................................................... 45&#13;
5.2.1 PECAM1 regulates endothelial platelet adhesion .................................................................................... 45&#13;
5.2.2 Endothelial reaction to CD31 mAb ................................................................................................................. 47&#13;
5.2.3 Endothelial reaction to hCD31 peptide ........................................................................................................ 50&#13;
5.2.4 Diverse signaling pathways ............................................................................................................................... 51&#13;
5.2.5 TNF-α ........................................................................................................................................................................... 54&#13;
5.3 HIVEP1 regulates endothelial platelet adhesion ............................................................................ 54&#13;
5.4 HIVEP1 regulates PECAM1 ...................................................................................................................... 56&#13;
5.5 Conclusion .................................................................................................................................................... 59&#13;
6 PERSPECTIVE ......................................................................................................... 60&#13;
7 REFERENCES .......................................................................................................... 61&#13;
ADDENDUM ............................................................................................................ 72&#13;
CONFERENCES ......................................................................................................... 73&#13;
LEBENSLAUF ............................................................................................................ 74&#13;
DANKSAGUNG ......................................................................................................... 75</mods:tableOfContents>
                  <mods:targetAudience>specialized</mods:targetAudience>
                  <mods:subject>
                    <mods:topic lang="ger">Venöse Thrombose; Endothel; HIVEP1; PECAM1; Thrombozyten; Adhäsion</mods:topic>
                  </mods:subject>
                  <mods:subject>
                    <mods:topic lang="eng">Venous thrombosis; endothelium; HIVEP1; PECAM1; platelets; adhesion</mods:topic>
                  </mods:subject>
                  <mods:classification authority="ddc">610</mods:classification>
                  <mods:identifier type="urn">urn:nbn:de:hbz:6-64169660189</mods:identifier>
                  <mods:location>
                    <mods:url access="object in context">https://miami.uni-muenster.de/Record/94bab196-ece9-408d-adc2-7b54d937c8fe</mods:url>
                  </mods:location>
                  <mods:accessCondition type="use and reproduction">
                    <mods:extension>
                      <ma:maWrap xmlns:ma="http://memoryalpha.ulb.uni-muenster.de">
                        <ma:licence>
                          <ma:displayLabel>CC BY 4.0</ma:displayLabel>
                          <ma:targetUrl>http://creativecommons.org/licenses/by/4.0/</ma:targetUrl>
                        </ma:licence>
                      </ma:maWrap>
                    </mods:extension>
                  </mods:accessCondition>
                  <mods:recordInfo>
                    <mods:recordIdentifier>oai:wwu.de:94bab196-ece9-408d-adc2-7b54d937c8fe</mods:recordIdentifier>
                  </mods:recordInfo>
                </mods:mods>
              </mets:xmlData>
            </mets:mdWrap>
          </mets:dmdSec>
          <mets:amdSec ID="AMD_94bab196-ece9-408d-adc2-7b54d937c8fe">
            <mets:rightsMD ID="RIGHTSMD_94bab196-ece9-408d-adc2-7b54d937c8fe">
              <mets:mdWrap MDTYPE="OTHER" MIMETYPE="text/xml" OTHERMDTYPE="DVRIGHTS">
                <mets:xmlData>
                  <dv:rights xmlns:dv="http://dfg-viewer.de/">
                    <dv:owner>Universitäts- und Landesbibliothek Münster</dv:owner>
                  </dv:rights>
                </mets:xmlData>
              </mets:mdWrap>
            </mets:rightsMD>
            <mets:digiprovMD ID="DIGIPROVMD_94bab196-ece9-408d-adc2-7b54d937c8fe">
              <mets:mdWrap MDTYPE="OTHER" MIMETYPE="text/xml" OTHERMDTYPE="DVLINKS">
                <mets:xmlData>
                  <dv:links xmlns:dv="http://dfg-viewer.de/">
                    <dv:reference>https://miami.uni-muenster.de/Record/94bab196-ece9-408d-adc2-7b54d937c8fe</dv:reference>
                    <dv:presentation/>
                  </dv:links>
                </mets:xmlData>
              </mets:mdWrap>
            </mets:digiprovMD>
          </mets:amdSec>
          <mets:fileSec>
            <mets:fileGrp USE="DEFAULT">
              <mets:file MIMETYPE="application/pdf" CHECKSUM="968c9fbef4d48cd36fc92c1c41a88c324e0a84763f509a6929d88007e0b3cd17" CREATED="2019-07-19T07:38:20" CHECKSUMTYPE="SHA-256" SIZE="10333385" ID="ID_FIL_diss_baar.pdf_DEFAULT">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/document/miami/94bab196-ece9-408d-adc2-7b54d937c8fe/diss_baar.pdf" LOCTYPE="URL"/>
              </mets:file>
            </mets:fileGrp>
            <mets:fileGrp USE="DOWNLOAD">
              <mets:file MIMETYPE="application/pdf" ID="DOW94bab196-ece9-408d-adc2-7b54d937c8fe">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/transfer/miami/94bab196-ece9-408d-adc2-7b54d937c8fe" LOCTYPE="URL"/>
              </mets:file>
            </mets:fileGrp>
          </mets:fileSec>
          <mets:structMap TYPE="PHYSICAL">
            <mets:div ID="ID_PHY_94bab196-ece9-408d-adc2-7b54d937c8fe" TYPE="physSequence">
              <mets:div ID="ID_PHY_diss_baar.pdf">
                <mets:fptr FILEID="ID_FIL_diss_baar.pdf_DEFAULT"/>
              </mets:div>
            </mets:div>
          </mets:structMap>
          <mets:structMap TYPE="LOGICAL">
            <mets:div ADMID="AMD_94bab196-ece9-408d-adc2-7b54d937c8fe" DMDID="DMD_94bab196-ece9-408d-adc2-7b54d937c8fe" ID="ID_LOG_94bab196-ece9-408d-adc2-7b54d937c8fe" TYPE="Monograph">
              <mets:div ID="ID_LOG_ID_PHY_diss_baar.pdf"/>
            </mets:div>
          </mets:structMap>
          <mets:structLink>
            <mets:smLink xlink:from="ID_LOG_94bab196-ece9-408d-adc2-7b54d937c8fe" xlink:to="ID_PHY_94bab196-ece9-408d-adc2-7b54d937c8fe"/>
            <mets:smLink xlink:from="ID_LOG_ID_PHY_diss_baar.pdf" xlink:to="ID_PHY_diss_baar.pdf"/>
          </mets:structLink>
        </mets:mets>